Septerna is poised for a pivotal catalyst with upcoming Phase 1 data for SEP-631, targeting mast cell-driven diseases via ...

JS207, Junshi Biosciences’ independently developed recombinant humanized anti-PD-1/VEGF bispecific antibody, has demonstrated promising anti-tumor activity and a manageable safety profile in both ...

Deep in our cells, a wide range of processes are occurring constantly. These cellular processes rely on enzymes to act as catalysts and set off a series of molecular interactions. There are still many ...

Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...

Sometimes, transporting electrons from one cell to another is a team effort. In electroactive bacteria, that team is a group of proteins that shepherds electrons forward, passing them along like a ...

Subcutaneous (SC) amivantamab reduces administration from hours to minutes, with efficacy and safety consistent with intravenous (IV) amivantamab1,2,3,4,5 ...

The Delhi Police on February 15 arrested eight people in connection with a terror module linked to anti-national activities, according to Additional CP (Special Cell) Pramod Singh Kushwaha. Of the ...

The Delhi Police have revealed that the terror suspects arrested in Tamil Nadu and West Bengal on Sunday had maintained regular contact with operatives in Bangladesh via the encrypted messaging ...

A Bangladeshi terror module handler, Shabbir, used Signal to direct operatives in India, sending funds for weapons and PDFs ...

Deep in the folds of the intestine, in microscopic pockets called crypts, a quiet surveillance system is always at work. Stem ...

(PTx) announced findings from a post hoc analysis of the eNRGy trial (NCT02912949) evaluating treatment beyond progression with zenocutuzumab in patients with advanced neuregulin 1 fusion-positive ...